Showing results (101-110 of 466) with videos related to
Sort By:
Pageof 47
Diabetes Care|March 1, 2006
Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE studyHans Ibsen, Michael H Olsen, Kristian Wachtell, et al.Journal of Hypertension|May 23, 2002
Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) StudySverre E Kjeldsen, Thomas Hedner, Jan Otto Syvertsen, et al.Circulation|August 1, 2007
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE StudyKristian Wachtell, Peter M Okin, Michael H Olsen, et al.Journal of Hypertension|February 2, 2016
Urinary catecholamines and the relationship with blood pressure and pharmacological therapyConstantinos G Missouris, Nirmala D Markandu, Feng J He, et al.Circulation. Arrhythmia and Electrophysiology|October 8, 2009
Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE studyPeter M Okin, Kristian Wachtell, Sverre E Kjeldsen, et al.Circulation Research|November 10, 2007
Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathwaysKarl E Herbert, Yogita Mistry, Richard Hastings, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|January 20, 2020
The first study comparing a wearable watch-type blood pressure monitor with a conventional ambulatory blood pressure monitor on in-office and out-of-office settingsKazuomi Kario, Daichi Shimbo, Naoko Tomitani, et al.European Heart Journal Open|August 3, 2022
Survey on arterial hypertension management: a report from the ESC Council for Cardiology Practice and the ESC Council on HypertensionCostantino Mancusi, Giovanni de Simone, Riccardo Asteggiano, et al.Archives of Internal Medicine|June 30, 2010
Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participantsKausik K Ray, Sreenivasa Rao Kondapally Seshasai, Sebhat Erqou, et al.Ebiomedicine|June 5, 2025
The relationship of baseline high-sensitivity C-reactive protein with incident cardiovascular events and all-cause mortality over 20 yearsAdam Hartley, Somayeh Rostamian, Amit Kaura, et al.Pageof 47